What is Opus Ksd?
Opus KSD, Inc. is at the forefront of medical device innovation, specializing in the development of the SubQ It! bioabsorbable skin closure system. This disposable stapler is engineered for the subcutaneous closure of small and laparoscopic incisions, offering a substantial improvement over traditional suturing methods. The SubQ It! system is designed to provide optimal wound closure up to seven times faster than conventional sutures, while crucially eliminating patient discomfort and the need for post-operative staple removal. Having achieved FDA clearance, the product is specifically targeted at minimally invasive surgery applications, positioning it as an indispensable tool for surgeons seeking efficiency and improved patient outcomes. The system is recognized for its ability to minimize scarring and ensure effective, rapid incision closure, marking a significant advancement in surgical technology.
How much funding has Opus Ksd raised?
Opus Ksd has raised a total of $500K across 1 funding round:
Private Equity
$500K
Private Equity (2016): $500K, investors not publicly disclosed
What's next for Opus Ksd?
The substantial enterprise-level funding and recent strategic investment indicate Opus Ksd is poised for accelerated scaling and market expansion. This capital infusion will likely fuel further research and development, enhance manufacturing capabilities, and broaden the commercial reach of the SubQ It! system. The company's focus on minimally invasive surgery aligns with a growing trend in healthcare, suggesting a strong potential for market adoption and revenue growth. Future strategic initiatives may include expanding the product line, pursuing international regulatory approvals, and forging key partnerships within the healthcare ecosystem to solidify its position as a leader in advanced wound closure solutions.
See full Opus Ksd company page
